Latest / Possible with Reid Hoffman
Daphne Koller on drug discovery and AI
How can scientists leverage AI and machine learning to more effectively research, develop, and deliver new drugs? This week, Reid and Aria talk drug development with renowned computer scientist and executive Dr. Daphne Koller, whose company, insitro, uses machine learning to improve the quality and speed of drug discovery. She addresses several ways AI and ML are already being used to redefine diseases and create better therapeutic interventions. Plus, she shares her experience transitioning from academia to industry.
Read the transcript of this episode here…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.